Allogeneic Transplantation With CCR5 Δ32/Δ32 Cord Blood Hematopoietic Cells in an HIV-1-Infected Patient
Background: The Berlin patient provides the only evidence to date of long-term control of HIV-1 infection after an allogeneic hematopoietic cell transplantation (HCT). Low prevalence of Δ32/Δ32 genotype (<1%) made the search for “patient number 2” unsuccessful for years. Since just a 4/6 match is necessary for cord blood transplantations (CBT), chances to find a…